By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Daxor Corporation 

350 Fifth Avenue, Suite 7120

New York  New York  10118  U.S.A.
Phone: 212-244-0555 Fax: 212-244-0806


Medical Device

Company News
Daxor Corporation (DXR) Announces Dividend, Patent Approval, Title Change 11/21/2016 12:55:33 PM
Daxor Corporation (DXR) Release: Two New Studies From Mayo Clinic And Lankenau Medical Center Presented At Heart Failure Society Of America 2016 Highlight Unique Ability Of BVA To Identify High Risk At Discharge In Hospitalized Heart Failure Patients 9/29/2016 11:35:18 AM
Daxor Corporation (DXR) Announces Filing Of Form N-CSR for June 30, 2016 9/15/2016 10:10:08 AM
Daxor Corporation (DXR) Announces Hiring of Chief Financial Officer 6/17/2016 11:41:53 AM
Daxor Corporation (DXR) Announces Upcoming Filing Of Form N-CSR For December 31, 2015 And Recent Developments 3/1/2016 12:57:01 PM
Daxor Corporation (DXR) Announces Return Of Dr. Joseph Feldschuh After Pancreatic Cancer Surgery 2/17/2016 11:59:27 AM
Daxor Corporation (DXR) Announces Sale Of BVA-100 Blood Volume Analyzer To Nebraska Medicine 2/8/2016 12:21:24 PM
Daxor Corporation (DXR) Announces An Increased Dividend And The Appointment Of Michael Feldschuh As President And Chief Executive Officer On A Temporary Basis 12/11/2015 11:05:12 AM
Second Heart Failure Study From The Mayo Clinic Utilizing Daxor Corporation (DXR)'s BVA-100 Blood Volume Analyzer Published In Journal Of Cardiovascular Trans. Res. (2015) 8:404-410 11/30/2015 2:03:26 PM
Daxor Corporation (DXR) Announces Filing Of Form N-Q For September 30, 2015 11/30/2015 2:00:44 PM